The PennZone

CARTHAGE, Mo. - PennZone -- Stratum Nutrition is pleased to announce that ESM Technologies, LLC recently received Notices of Allowance for two different patents in two new geographic regions.

One of the patents, 'Methods for Treating NF-kB Dysregulation in a Host in Need Thereof Using Eggshell Membrane Compositions' was first issued in the U.S. in 2019 (US 10,328,104) and has recently been allowed by the European Patent Office.  This invention deals with a whole host of conditions and diseases related to NF-kB dysregulation including: pulmonary, gastrointestinal, cardiovascular, & nervous system.

The other patent, 'Method for Evaluating Articular Joint Therapeutics' was first issued in the U.S. in 2018 (US 9,983,214) and has recently been allowed by the Canadian Intellectual Property Office.  This invention deals with a clinical trial design using the cartilage degradation biomarker CTX-II to evaluate articular joint therapeutics for chondroprotective efficacy.  Both patents are still pending in multiple additional jurisdictions.

"We are excited to extend our patent protection to additional geographies.  This is particularly true for our CTX-II clinical model patent, which has now been allowed in the U.S., Europe, Canada, Japan, and several other countries.  We have used this patented model in multiple clinical trials to demonstrate that our flagship ingredient, NEM® brand eggshell membrane, helps to protect cartilage in exercising individuals.", said Kevin Ruff, Stratum's Sr. Director of Scientific & Regulatory Affairs.

More on The PennZone

• Sleep Basil Unveils Revamped Natural Latex Mattress Collection Page for Cooler, Cleaner, Better-Aligned Sleep
• Conexwest Delivers Custom Shipping Container MRI Lab, Saving California Hospital an Estimated $9 Million in Renovation Costs
• Smallville, Sailor Moon, Reno 911! Stars Added To FAN EXPO Philadelphia Lineup, May 29-31
• FDA Meeting Indicates a pivotal development that could redefine the treatment landscape for suicidal depression via NRx Pharmaceuticals: $NRXP
• $2.7 Million 2025 Revenue; All Time Record Sales Growth; 6 Profitable Quarters for Homebuilding Industry: Innovative Designs (Stock Symbol: IVDN)

For more information about Stratum Nutrition^® and its branded ingredients, please visit www.stratumnutrition.com.

###

About Stratum Nutrition

Stratum Nutrition^®, a business of ESM Technologies, LLC, sustainably provides world class nutrition ingredient solutions to nutritional product formulators for human and pet health. Stratum offers a portfolio of research-supported, branded ingredients that are progressive, safe and effective, including NEM^® brand eggshell membrane, ESC^® brand eggshell calcium, Ahiflower^® plant-based omegas-3,6,9, Curcumin 95, curQplus™, LBiome™ Lactobacillus LB postbiotic, NatAxtin™ astaxanthin, as well as oral health probiotics, BLIS K12^® and BLIS M18^®. These trusted ingredients are relied upon by consumers internationally. Visit www.stratumnutrition.com for more information.